samedan logo
 
 
 
spacer
home > ebr > winter 2001 > 9th annual biopartnering europe event
PUBLICATIONS
European Biopharmaceutical Review

9th Annual BioPartnering Europe Event

The formula and track record for Technology Vision Group's annual partnering event is now well-established at the Queen Elizabeth Conference Centre in London. Every year it successfully brings together senior biotech and pharma representatives from all over the world, as well as investors, consultants, lawyers and regional groups. This year's event was no exception with over 1,100 delegates attending to make maximal use of the networking opportunities and technology showcases. There was also the chance to hear from some well known industry names voicing a view on the status of the sector in Q4, 2001.As in previous years, albeit amid tighter security on this occasion, the meeting kicked off with the regional delegation receptions on the Sunday evening. These featured both national and regional biotechnology associations from a range of European and North American territories, including for the first time 'Invest Australia'.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott, Editor of EBR
spacer
Dr Helen Abbott
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Insightful Science Acquires Protein Metrics to Expand its R&D Solution to Include Proteomics

San Diego, CA, 21 December 2021: Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire Protein Metrics, Inc., a leading provider of biopharmaceutical protein characterization and proteomics analysis software. The acquisition expands the Company’s R&D value chain to widen the biopharmaceutical protein analysis arena, unblocking data analysis bottlenecks currently associated with large-scale protein studies.
More info >>

White Papers

Digital Transformation of the Cold Chain

Sensitech EMEA

The Life Sciences cold chain is a seamless and interconnected global network of people, equipment, data and processes that helps to ensure the safety and integrity of our medicines and vaccines. Cold chain logistics spending totaled $13 billion in 2017, an investment designed to protect some $283 billion in Life Sciences cold chain products, growing at 19% annually.1 Sensitech Inc., a part of UTC Climate, Controls & Security, a unit of United Technology Corp., has played an essential part in the Life Sciences cold chain since 1990, providing a comprehensive set of solutions for manufacturers of biologics, prescription pharmaceuticals, clinical trial materials, and over-the-counter drugs. These solutions help to ensure product quality, patient safety, and regulatory compliance while helping to prevent theft and optimizing cold chain performance.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement